First, we showed that GNA potentiated the inhibitory effect of erlotinib on lung cancer cell proliferation, colony formation, tumor growth, and EGFR phosphorylation, which correlated with the inhibition of cMet activity. The gene discussed is EGFR; the disease is lung carcinoma.